Skip to main content

Dr Curran and Partners – Clinical Update 25 May 2023

 1. Covid-19 vaccination: Spring booster campaign currently underway for high-risk groups. Offers of first and second Covid-19 vaccinations for low-risk people who are currently unvaccinated will come to an end after 30 June.

2.  Monkeypox (mpox) vaccination: Anyone who is eligible for mpox vaccine should come forward for vaccination. First doses of vaccine remain available until June for gay, bisexual and men who have sex with men (GBMSM) at highest risk from mpox with second doses available until the end of July.

3. Patient choice: Patients will be able to choose from up to five different providers through the NHS app when they are referred by a GP for specialist treatment. In practice, this may not have much impact because many patients will choose to be referred to the closest hospital; others will know what hospital they want to use; and most of the rest will rely on the judgement of their GP.

4. Pharmacist access to GP records: Community pharmacists will be able to access and add to patient records currently maintained by GPs by the end of 2023.

5. Labour Party health policy: Labour likely to review the GP partnership model if they are elected as the next government. The Labour Party also want a much bigger focus on using digital health tools.


Comments

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...

UK Covid-19 Inquiry - The Importance of a Strong Primary Healthcare System

In my witness statement for Module 10 of the UK Covid-19 Inquiry, I discuss the pandemic's impact through from the perspectives of  primary care and public health, drawing on my extensive experience as a senior academic at Imperial College London and as a practising GP and NHS Public Health Specialist.  I emphasise that the pandemic disproportionately affected people who were clinically vulnerable, the disabled, ethnic minority communities and those living in deprived areas. The pandemic highlighted how structural inequalities, multigenerational housing, and employment in high-risk frontline roles exacerbated health disparities.  My statement also critiques the weakening of public health infrastructure - particularly for the control of infectious diseases - and the lack of integrated health data systems to identify at-risk groups such as the clinically vulnerable. I also advocated for a more robust preventive healthcare model that prioritises community-based primary care ...

Protecting Young People from Meningococcal B Disease: The NHS Targeted Vaccination Programme

Meningococcal group B (MenB) infections are rare but can have devastating consequences. The decision to offer a targeted two-dose vaccination programme to Year 13 students and young people entering university or residential further education reflects concerns about recent outbreaks of meningococcal disease and the higher risk of transmission when large numbers of young adults mix closely for the first time in shared accommodation. The MenB vaccine has a well-established safety record, and evidence from the UK infant immunisation programme has shown substantial reductions in disease among vaccinated children. A targeted programme for those entering higher-risk settings is therefore a reasonable precautionary measure while further evidence is gathered on whether the recent increase in clusters represents a temporary fluctuation in disease patterns or a more sustained change in the epidemiology of MenB infection. The success of the programme will depend on achieving high uptake and ensuri...